The next major drugmaker interested in what Repertoire has to offer is Eli Lilly, which has thrown down $85 million upfront and floated up to $1.84 billion more in biobucks to collaborate on potential ...
Manyfold issued a big release of new features for their open source, distributed 3D model repository software.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results